Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures mRNA Vaccine Platform Shows Promise Against Pandemic Influenza Strains, Including H5N1Global Biodefense StaffApril 26, 2026
Medical Countermeasures UK Launches Phase 3 Trial of mRNA H5N1 Vaccine in Bid to Get Ahead of Next PandemicGlobal Biodefense StaffApril 23, 2026
Soligenix Wins Additional 4.3M to Advance Ricin Vaccine Manufacturing Contracts + Grants May 5, 2016 …
BARDA Awards Contract to Basilea for Broad-Spectrum Antibiotic Antimicrobial Resistance April 22, 2016 …
Federal Perspective on the State of Our Nation’s Biodefense Antimicrobial Resistance April 18, 2016 …
